1.49
1.49 (-0.64%)
As of Mar 06, 2024
Akebia Therapeutics, Inc. [AKBA]
Source:
Company Overview
Akebia Therapeutics, Inc. manufactures biopharmaceutical products. The Company develop and distributes novel therapeutics based on the biology of hypoxia inducible factor (HIF) for patients with kidney diseases. Akebia Therapeutics serves customers in the United States.
| Country | United States |
| Headquarters | cambridge, massachusetts |
| Phone Number | 617-871-2098 |
| Industry | manufacturing |
| CEO | John P. Butler |
| Website | www.akebia.com |